| 177 |
Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality |
Kellie Fay |
BY-SA |
1103: Inhibition, Cyclooxygenase 1 activity
|
2 AOs
|
|
|
| 178 |
Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure |
Carlie LaLone |
BY-SA |
559: Activation, Nicotinic acetylcholine receptor
|
563: Death/Failure, Colony
|
|
|
| 179 |
Varroa mite infestation increases virus levels leading to colony loss/failure |
Carlie LaLone |
BY-SA |
None
|
563: Death/Failure, Colony
|
|
|
| 180 |
Varroa mite infestation contributes to abnormal foraging leading to colony loss/failure |
Carlie LaLone |
BY-SA |
None
|
563: Death/Failure, Colony
|
|
|
| 181 |
Weather event contributes to colony loss/failure |
Carlie LaLone |
BY-SA |
None
|
563: Death/Failure, Colony
|
|
|
| 182 |
Weather event contributes abnormal foraging leading to colony loss/failure |
Carlie LaLone |
BY-SA |
None
|
563: Death/Failure, Colony
|
|
|
| 183 |
Nosema infection increases energetic demands leading to colony loss/failure |
Carlie LaLone |
BY-SA |
None
|
563: Death/Failure, Colony
|
|
|
| 286 |
Mitochondrial complex III antagonism leading to growth inhibition (1) |
You Song |
BY-SA |
1542: Inhibition, Mitochondrial complex III
|
1521: Decrease, Growth
|
|
|
| 229 |
Helicobacter pylori to gastric ulcer |
Lyle Burgoon |
Open for adoption |
1412: Helicobacter pylori infection
|
1385: Activated, gastric ulcer formation
|
|
|
| 230 |
presynaptic neuron 1 activation to epilepsy |
Lyle Burgoon |
Open for adoption |
1349: Activated, presynaptic neuron 1
|
1363: Increased, epilepsy
|
|
|
| 231 |
presynaptic neuron 2 repression to epilepsy |
Lyle Burgoon |
Open for adoption |
1413: Reduced, presynaptic neuron 2 activity
|
1363: Increased, epilepsy
|
|
|
| 232 |
NFE2/Nrf2 repression to steatosis |
Lyle Burgoon |
Open for adoption |
1417: NFE2/Nrf2 repression
|
459: Increase, Liver steatosis
|
|
|
| 233 |
Mu Opioid Receptor Agonism leading to Analgesia via K Channel Opening |
Timothy Allen |
BY-SA |
1425: Mu Opioid Receptor Agonism
|
1428: Analgesia
|
|
|
| 234 |
Mu Opioid Receptor Agonism leading to Analgesia via Ca Channel Inhibition |
Timothy Allen |
BY-SA |
1425: Mu Opioid Receptor Agonism
|
1428: Analgesia
|
|
|
| 235 |
Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via K Channel Opening |
Timothy Allen |
BY-SA |
1431: Serotonin 1A Receptor Agonism
|
1432: Anti-depressant Activity
|
|
|
| 236 |
Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via Ca Channel Inhibition |
Timothy Allen |
BY-SA |
1431: Serotonin 1A Receptor Agonism
|
1432: Anti-depressant Activity
|
|
|
| 239 |
Oxidative Stress Leading to ILC2-mediated Respiratory Epithelial Remodeling |
Undefined |
BY-SA |
None
|
None
|
|
|
| 240 |
DNA Adducts Leading to Liver Hemangiosarcoma |
Undefined |
BY-SA |
None
|
None
|
|
|
| 228 |
NSAID induced PTGS2 inactivation to gastric ulcer |
Lyle Burgoon |
Open for adoption |
1408: Reduced, PTGS2 function
|
1385: Activated, gastric ulcer formation
|
|
|
| 287 |
Mitochondrial complex III antagonism leading to growth inhibition (2) |
You Song |
BY-SA |
1542: Inhibition, Mitochondrial complex III
|
1521: Decrease, Growth
|
|
|
| 290 |
Mitochondrial ATP synthase antagonism leading to growth inhibition (1) |
You Song |
BY-SA |
1785: Increase, Mitochondrial ATP synthase antagonism
|
1521: Decrease, Growth
|
|
|
| 291 |
Mitochondrial ATP synthase antagonism leading to growth inhibition (2) |
You Song |
BY-SA |
1785: Increase, Mitochondrial ATP synthase antagonism
|
1521: Decrease, Growth
|
|
|
| 299 |
Deposition of energy leading to population decline via DNA oxidation and follicular atresia |
You Song |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 336 |
DNA methyltransferase inhibition leading to population decline (1) |
You Song |
BY-SA |
1619: Increase, DNA methyltransferase inhibition
|
2 AOs
|
|
|
| 337 |
DNA methyltransferase inhibition leading to population decline (2) |
You Song |
BY-SA |
1619: Increase, DNA methyltransferase inhibition
|
2 AOs
|
|
|